The kidneys play an essential role in maintaining overall health by filtering waste and excess fluid from the blood. They also help keep important proteins and other substances within the bloodstream. When the kidney's filtering structures become damaged, protein can leak into the urine, a problem known as proteinuria.

Several rare kidney diseases can cause significant protein loss and affect kidney function over time. Congenital nephrotic syndrome, focal segmental glomerulosclerosis (FSGS), and IgA nephropathy are three conditions that can affect the kidneys in different ways. Understanding their symptoms, causes, and available treatment approaches can help patients and families have more informed conversations with their healthcare teams.

Congenital Nephrotic Syndrome

Congenital nephrotic syndrome is a rare kidney disorder that develops during the first months of life. It is characterized by significant protein loss through the kidneys. Because proteins such as albumin help maintain fluid balance within the bloodstream, losing large amounts through the urine can lead to swelling and other complications.

Infants with congenital nephrotic syndrome may experience symptoms such as swelling around the eyes, swelling in the legs or abdomen, poor growth, and increased susceptibility to infections. Significant protein loss can also contribute to nutritional deficiencies and other medical complications.

Congenital Nephrotic Syndrome Treatment

Congenital nephrotic syndrome treatment is individualized according to the underlying cause, severity of protein loss, age, nutritional status, and overall health of the child.

Management may focus on reducing complications associated with protein loss and supporting healthy growth. Depending on the child's needs, treatment may involve medications, nutritional support, replacement of certain proteins or other substances, and careful monitoring of fluid and electrolyte balance.

In some cases, children with severe congenital nephrotic syndrome may eventually require specialized kidney treatment, including dialysis or kidney transplantation. Because the condition can be complex, care is often provided by a multidisciplinary team that may include pediatric nephrologists, dietitians, and other specialists.

Early recognition and ongoing monitoring are important because congenital nephrotic syndrome can significantly affect a child's growth and development as well as kidney health.

Focal Segmental Glomerulosclerosis

Focal segmental glomerulosclerosis, commonly called FSGS, is a kidney disease involving scarring in parts of the glomeruli. Glomeruli are tiny filtering structures within the kidneys that help remove waste and excess fluid from the blood.

FSGS can occur in children or adults and may develop for different reasons. Some cases are associated with genetic factors, while others may be linked to another medical condition or an identifiable cause. In some patients, the cause remains unknown.

Proteinuria is a common feature of FSGS. Depending on the severity of the disease, patients may also experience swelling, high blood pressure, changes in urine, or declining kidney function.

Focal Segmental Glomerulosclerosis Treatment

The approach to focal segmental glomerulosclerosis treatment depends on whether the disease is primary, genetic, or secondary to another condition.

Treatment may focus on reducing protein loss, controlling blood pressure, protecting remaining kidney function, and addressing the underlying cause when one is identified. Some patients may receive medications that affect the immune system, while others may benefit from therapies aimed at reducing proteinuria and managing cardiovascular or kidney-related risks.

Lifestyle and supportive measures can also be an important part of care. A healthcare professional may provide individualized guidance regarding diet, blood pressure monitoring, medications, and other factors that influence kidney health.

Because FSGS can progress differently from one person to another, regular monitoring is important. Blood and urine testing can help healthcare professionals evaluate kidney function and determine whether treatment needs to be adjusted.

IgA Nephropathy

IgA nephropathy, also known as Berger disease, is a kidney disease that develops when a type of antibody called immunoglobulin A, or IgA, accumulates in the kidneys. These deposits can cause inflammation and damage to the glomeruli.

The condition can affect people differently. Some individuals have relatively mild disease, while others may experience progressive kidney damage.

IgA Nephropathy Symptoms

IgA nephropathy symptoms can vary depending on the severity of kidney involvement. One of the most noticeable signs may be blood in the urine, which can make the urine appear pink, red, or cola-colored.

Other possible signs include:

• Foamy urine caused by protein in the urine
• Swelling in the legs, ankles, feet, or around the eyes
• High blood pressure
• Changes in kidney function
• Fatigue in some individuals

In some cases, IgA nephropathy may be discovered through routine urine or blood testing before noticeable symptoms develop. This is one reason regular medical evaluation can be valuable for individuals who have risk factors or abnormal kidney test results.

How These Kidney Diseases Are Evaluated

Although congenital nephrotic syndrome, FSGS, and IgA nephropathy can all involve proteinuria, they are distinct diseases and require different approaches to diagnosis and management.

Healthcare professionals may use several types of testing to evaluate suspected kidney disease. Urine tests can measure protein and blood, while blood tests can assess kidney function and other important markers.

Imaging studies may sometimes be used to examine the kidneys. In selected cases, a kidney biopsy may be recommended to examine kidney tissue under a microscope. Genetic testing may also be considered, particularly when a hereditary kidney disease is suspected.

An accurate diagnosis is important because treatment decisions depend heavily on the underlying cause and type of kidney disease.

The Importance of Ongoing Kidney Care

Protein-spilling kidney diseases can require long-term monitoring. Even when symptoms are limited, kidney damage can sometimes progress gradually. Regular appointments allow healthcare professionals to monitor urine protein levels, blood pressure, kidney function, and other indicators of disease activity.

Patients should also communicate new or worsening symptoms to their healthcare team. Swelling, significant changes in urine, increasing blood pressure, or other concerning changes may warrant medical evaluation.

Supporting Patients and Families

Living with a rare kidney disease can be challenging for both patients and families. Access to reliable educational information can help people understand their diagnosis and participate more confidently in treatment discussions.

Organizations dedicated to rare kidney diseases can also provide educational resources, community support, and information about ongoing research. For families dealing with conditions such as congenital nephrotic syndrome, FSGS, or IgA nephropathy, these resources can complement—not replace—care from qualified healthcare professionals.

Conclusion

Congenital nephrotic syndrome, FSGS, and IgA nephropathy are different kidney diseases, but each can affect the kidney's filtering function and contribute to protein or blood appearing in the urine. Congenital nephrotic syndrome typically presents early in life and requires specialized management, while FSGS involves scarring within the kidney's filtering structures. IgA nephropathy is associated with IgA deposits and may present with blood or protein in the urine.

Recognizing potential symptoms and obtaining an accurate diagnosis are important steps toward appropriate care. Treatment is highly individualized and may involve medications, supportive therapies, nutritional management, monitoring, or advanced kidney care depending on the disease and its severity.

Anyone experiencing symptoms or abnormal kidney test results should discuss them with a qualified healthcare professional. Early evaluation and continued monitoring can help patients and families better understand their condition and make informed decisions about kidney health.